Although TRIM29 is primarily an E3 ubiquitin ligase, our in silico findings indicate that TRIM29 contributes to multiple hallmarks of cancer pertaining to tumor progression and chemo-resistance. This evidence concerns the gene TRIM29 and neoplasm.